Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Edward M Kennedy

Showing results (11-20 of 57) with videos related to

Pageof 6
Sort By:
Health Affairs (Project Hope)|May 9, 2007
Risk management and intrusions on medical practice: striking a balanceMichael B Enzi, Edward M Kennedy
Virology|March 12, 2015
Bacterial CRISPR/Cas DNA endonucleases: A revolutionary technology that could dramatically impact viral research and treatmentEdward M Kennedy, Bryan R Cullen
Boston University Journal|January 1, 1976
A letter to the President on recombinant DNA researchEdward M Kennedy, Jacob K Javits
Annual Review of Medicine|August 31, 2016
Gene Editing: A New Tool for Viral DiseaseEdward M Kennedy, Bryan R Cullen
Biochemistry|October 13, 2009
The mechanistic architecture of thermostable Pyrococcus furiosus family B DNA polymerase motif A and its interaction with the dNTP substrateEdward M Kennedy, Christopher Hergott, Stephen Dewhurst, et al.
Antiviral Research|October 18, 2015
Targeting hepatitis B virus cccDNA using CRISPR/Cas9Edward M Kennedy, Anand V R Kornepati, Bryan R Cullen
Molecular Biology International|July 20, 2012
The Impact of Macrophage Nucleotide Pools on HIV-1 Reverse Transcription, Viral Replication, and the Development of Novel Antiviral AgentsChristina Gavegnano, Edward M Kennedy, Baek Kim, et al.
Journal of Virology|March 3, 2017
Viral EpitranscriptomicsEdward M Kennedy, David G Courtney, Kevin Tsai, et al.
Nucleic Acids Research|January 28, 2014
Differential RISC association of endogenous human microRNAs predicts their inhibitory potentialOmar Flores, Edward M Kennedy, Rebecca L Skalsky, et al.
RNA (New York, N.Y.)|June 16, 2018
Influenza A virus-derived siRNAs increase in the absence of NS1 yet fail to inhibit virus replicationKevin Tsai, David G Courtney, Edward M Kennedy, et al.
Pageof 6

Showing results (11-20 of 57) with videos related to

Sort By:
Pageof 6
Health Affairs (Project Hope)|May 9, 2007
Risk management and intrusions on medical practice: striking a balanceMichael B Enzi, Edward M Kennedy
Virology|March 12, 2015
Bacterial CRISPR/Cas DNA endonucleases: A revolutionary technology that could dramatically impact viral research and treatmentEdward M Kennedy, Bryan R Cullen
Boston University Journal|January 1, 1976
A letter to the President on recombinant DNA researchEdward M Kennedy, Jacob K Javits
Annual Review of Medicine|August 31, 2016
Gene Editing: A New Tool for Viral DiseaseEdward M Kennedy, Bryan R Cullen
Biochemistry|October 13, 2009
The mechanistic architecture of thermostable Pyrococcus furiosus family B DNA polymerase motif A and its interaction with the dNTP substrateEdward M Kennedy, Christopher Hergott, Stephen Dewhurst, et al.
Antiviral Research|October 18, 2015
Targeting hepatitis B virus cccDNA using CRISPR/Cas9Edward M Kennedy, Anand V R Kornepati, Bryan R Cullen
Molecular Biology International|July 20, 2012
The Impact of Macrophage Nucleotide Pools on HIV-1 Reverse Transcription, Viral Replication, and the Development of Novel Antiviral AgentsChristina Gavegnano, Edward M Kennedy, Baek Kim, et al.
Journal of Virology|March 3, 2017
Viral EpitranscriptomicsEdward M Kennedy, David G Courtney, Kevin Tsai, et al.
Nucleic Acids Research|January 28, 2014
Differential RISC association of endogenous human microRNAs predicts their inhibitory potentialOmar Flores, Edward M Kennedy, Rebecca L Skalsky, et al.
RNA (New York, N.Y.)|June 16, 2018
Influenza A virus-derived siRNAs increase in the absence of NS1 yet fail to inhibit virus replicationKevin Tsai, David G Courtney, Edward M Kennedy, et al.
Pageof 6